- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03298776
I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions
The use of endoscopy for the diagnosis of gastrointestinal diseases has continued to increase in recent years.
Endoscopy provides an advantage over other noninvasive or minimally invasive procedures in that it allows both direct visualisation of the mucosa but direct and accurate sampling of abnormalities for histological examination. However standard endoscopy does have some limitations particularly with small lesions and pan mucosal changes. Some lesions may be entirely benign and require no further intervention but as a result of difficulty with accurate endoscopic characterization of lesions in many cases unnecessary biopsies or polypectomies are undertaken. Therefore any technology that can augment the use of standard endoscopy to minimise unnecessary intervention should be encouraged. IScan is a digital enhancement technique available with Pentax endoscopes. There have been other novel endoscopic advances for example, Narrow band imaging but these have not been adopted widely for a number of reasons including technical difficulties or patient tolerability. The aim of this study is to assess whether Pentax IScan technology is a reliable method of improving our recognition of macroscopic mucosal lesions compared to standard white light endoscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All patients recruited will undergo standard endoscopy using current generation Pentax endoscopes. These endoscopes are widely used for standard endoscopic procedures. All of the endoscopes that will be used have the I-scan function which is controlled by the operator. Therefore there will be no difference between the groups randomised to I-Scan or standard endoscopy, other than a very slight difference in duration for I-scan, which the patient is unlikely to detect. We have received no funding from Pentax for the use of their endoscopes.
Following recruitment patients will be randomly allocated to receive standard white light endoscopy or standard white light endoscopy plus I-Scan using a random number generator at www.random.org with possible values of 0 or 1. Those with a 0 will receive standard endoscopy and those with a 1 will receive standard endoscopy plus I-Scan. Both arms will undergo standard endoscopic evaluation including appropriate biopsies by fully trained experienced endoscopists with Joint Advisory Group (JAG) accreditation for endoscopy. The investigators will be initially blinded to the indication for endoscopy until the I-Scan has been utilised at which point the indication will be revealed to ensure patient safety. Patients will have biopsies only by the clinical indication. No extra biopsies that would not normally be clinically justified will be taken. Following the procedure all patients will be asked to evaluate the tolerability of their test using a validated 10 point likert scale. All procedures will be recorded on an anonymised basis using a unique research identifier and subsequently reviewed by other expert endoscopists within the department to allow us to accurately assess the reliability and interobserver variability of the test. Each of the endoscopists will be fully trained in standard endoscopy and will be blinded to the indication for the procedure.
The study will be a randomised controlled trial. Given the nature of the study it is not possible to blind the investigators to the procedure type. The investigator carrying out the procedure will however be blinded to the indication for the procedure until the I-Scan has been used as this could lead to bias. The endoscopists reviewing the images will be blinded to all patient information and indications for the endoscopy throughout the study period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Yorkshire
-
Sheffield, South Yorkshire, United Kingdom, S10 2JF
- Royal Hallamshire Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients attending for a routine diagnostic endoscopic procedure where Pentax endoscopes are in use at the endoscopy unit at the Royal Hallamshire Hospital.
Exclusion Criteria:
- Patients attending for a therapeutic endoscopic procedure.
- Patients with a known endoscopic diagnosis
- Patients with abnormal coagulation or any other contraindication to use of standard biopsy or polypectomy techniques used in routine diagnostic endoscopic procedures
- Patients who are unable to understand English or give informed consent
- Patients under the age of 16
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: standard white light endoscopy
Patients will undergo the standard of care which is standard white light endoscopy
|
Patients referred for standard endoscopy to receive standard of care only
|
Experimental: Endoscopy and I-Scan
Patients will undergo standard of care endoscopy plus the I-Scan
|
I-Scan is a digital enhancement technique.
These endoscopes already have greater definition compared to many standard endoscopes but they also utilise a 'zoom' function and digital image enhancement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clarity of mucosal lesions found using I-Scan
Time Frame: through study completion, on average one year
|
The endoscopic assessment of mucosal lesions using standard endoscopy and standard endoscopy plus I-Scan Will be compared to histological assessment where this is indicated.
Interobserver variability of assessment of mucosal lesions will be compared between endoscopic techniques
|
through study completion, on average one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient reported tolerability of I-scan procedure
Time Frame: through study completion, on average one year
|
The use of the I-scan results in a slight prolongation of the endoscopy procedure.
A ten point likert patient reported questionnaire will assess patient tolerability of the I-scan
|
through study completion, on average one year
|
Collaborators and Investigators
Investigators
- Principal Investigator: David Sanders, Sheffield Teaching Hospitals Nhs Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STH18011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopy
-
Buddhist Tzu Chi General HospitalUnknownMethods of Nasal Anesthesia Before Transnasal Endoscopy | Side Effects of Transnasal Endoscopy | Patient's Tolerance to Transnasal EndoscopyTaiwan
-
Fujifilm Medical Systems USA, Inc.Completed
-
Children's Mercy Hospital Kansas CityCompletedEndoscopyUnited States
-
State University of New York - Upstate Medical...Completed
-
Tabriz UniversityCompleted
-
University of NebraskaChildren's Hospital and Medical Center, Omaha, NebraskaCompleted
-
Tongji HospitalRecruitingBidirectional EndoscopyChina
-
Stanford UniversityRecruitingEndoscopy | ColonoscopyUnited States
-
Changhai HospitalQilu Hospital of Shandong UniversityCompleted
Clinical Trials on Standard endoscopy
-
Technical University of MunichRotkreuzklinikum München gGmbH; Klinikum Freising; Klinikum Landshut-Achdorf; Städtisches... and other collaboratorsCompletedEndoscopic Diagnosis in EsophagusGermany
-
Mayo ClinicIntroMedic Co., Ltd.CompletedBarrett's EsophagusUnited States
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Vanderbilt UniversityCompleted
-
University of CalgaryAlberta Heritage Foundation for Medical Research; Calgary Health RegionCompleted
-
University of Southern CaliforniaRecruiting
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Dennis Hong MDVantage EndoscopyWithdrawn
-
Changhai HospitalPeking Union Medical College Hospital; Chinese PLA General Hospital; RenJi Hospital and other collaboratorsCompletedChronic Gastritis | Gastric Diseases, | Gastric Ulcer, | Gastric Polyps, | Early Gastric Cancer,China
-
Midwest Biomedical Research FoundationMedical University of South Carolina; Academisch Medisch Centrum - Universiteit... and other collaboratorsCompletedGastroesophageal Reflux | Barrett EsophagusUnited States, Netherlands